Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAK Cell Therapy in Late-stage Gastric Cancer
NCT07212933Phase 2Recruiting
- Sponsor
- Chinese PLA General Hospital
- Start
- Jul 2025
- Primary completion
- Dec 2027
- Modality
- Prophylactic Vaccines, Cell Therapies, Therapeutic Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of RAK cells in gastric cancer (GC), sponsored by Chinese PLA General Hospital. Started Jul 2025; status: recruiting.
02
Drugs
RAK cells
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT07212933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07212933.